Artelo Biosciences (ARTL) Stock Statistics & Valuation Metrics

Artelo Biosciences has a market cap or net worth of $8.35M. The enterprise value is $3.32M.

Artelo Biosciences has 704,425 shares outstanding. The number of shares has decreased by -2.65% in one year.

Artelo Biosciences’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -51.75%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Artelo Biosciences had revenue of 0.00 and earned -10.08M in profits. Earnings per share was -3.49.

In the last 12 months, operating cash flow was -7.80M and capital expenditures 0.00, giving a free cash flow of -7.80M billion.

Artelo Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Artelo Biosciences upcoming earnings date is Aug 6, 2025, TBA (Confirmed).

Artelo Biosciences as a current ratio of 18.36, with Debt / Equity ratio of 0.32%

In the past 12 months, Artelo Biosciences has paid -209.00K in taxes.

Artelo Biosciences EV to EBITDA ratio is -0.13, with an EV/FCF ratio of -0.17.

Artelo Biosciences has $13.99M in cash and marketable securities with $40.00K in debt, giving a net cash position of -$13.95M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Artelo Biosciences is $20.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy